1.Review and Analysis of Drugs Used in Enterprise Hospitals and Municipal Hospitals in Chongqing During 2001~2003 Period
China Pharmacy 2001;0(09):-
OBJECTIVE:To make clear the present status and developing trend of drugs used in enterprise hospitals and municipal hospitals in Chongqing between2001~2003to offer reference information for the departments concerned.METHO_ DS:The data of drugs used in enterprise and municipal hospitals in Chongqing were retrospectively analysed.RESULTS:In enterprise hospitals and municipal hospitals,the annual increasing rates of sales volumn of drugs were8.24%and18.29%;the anti-infectives accounted for40%~41%and36%~40%of annual sales volumn and sales volumn of imported drugs amounted to4.40%and14.78%of total drugs consumed respectively.CONCLUSION:The sales volumn of drugs in enterprise hospitals is decreasing year by year,while that in municipal hospitals is increasing.
2.The clinicopathologic characteristics and prognosis of 65 differentiated thyroid cancer patients with lung metastasis
Yongsheng JIA ; Dapeng LI ; Yan ZHANG ; Libu ZHANG ; Xiaoyong YANG ; Linfei HU ; Dong DAI ; Xiangqian ZHENG
Chinese Journal of General Surgery 2024;39(9):707-712
Objectives:To explore the clinicopathological characteristics and prognostic risk factors in differentiated thyroid cancer (DTC) patients with lung metastasis.Methods:Patients of differentiated thyroid cancer with lung metastasis in Tianjin Medical University Cancer Institute & Hospital were enrolled from Jan 1, 2010 to Dec 31, 2016. The clinicopathological characteristics and risk factors affecting the prognosis were analyzed retrospectively.Results:A total of 65 DTC patients with lung metastasis were collected in this study, including 56 patients with papillary thyroid carcinoma and 9 patients with follicular thyroid carcinoma; 23 patients died and 42 patients survived. Median follow-up time was 99.4 months. There were 18 males, 47 females. Age 14-73 years, median age 51.0 years. High incidence of DTC lung metastasis was 50-59 years for males and 40-49 years for females. Based on AJCC 8th edition TNM staging, there were 37 patients in stage Ⅱ (age <55 years) and 28 patients in stage Ⅳb (age ≥55 years). The number of 131Ⅰ treatments performed ranged from 1 to 13 times, with a mean of 3.9 times. Firty-five patients were with lung metastasis alone, and 10 patients with lung metastasis and distant metastasis in other organs. Eleven patients suffered from hypoparathyroidism after 131Ⅰ treatment. COX multifactorial regression analysis found that age was independent risk factor affecting prognosis, multiple organs distant metastasis and pathologic subtype were relative risk factors affecting prognosis. There was no correlation between gender, number of 131Ⅰ treatments and poor prognosis. Conclusions:DTC has a high survival even with the occurrence of lung metastasis, but the prognosis is poor when combined with multi-organ metastasis. Age and multiple organ distant metastatic are independent risk factors affecting prognosis.